ChemDiv is now the recognized global leader in discovery chemistry
We have the industry's largest, most diverse, and most pharmacologically-relevant commercial collection of almost 1,600,000 individually crafted, lead-like, drug-like small molecules. ChemDiv executes pre-clinical discovery chemistry and biology for drug development and clinical trials for an international portfolio of companies across the entire range of targets with small molecule and biotech drugs.